| For: | El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. World J Gastroenterol 2021; 27(18): 2219-2237 [PMID: 34025075 DOI: 10.3748/wjg.v27.i18.2219] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i18/2219.htm |
| Number | Citing Articles |
| 1 |
Zixuan Cao, Tingting Gao, Ousman Bajinka, Yali Zhang, Xingxing Yuan. Fecal microbiota transplantation-current perspective on human health. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1523870
|
| 2 |
Marina Ninkov, Saman Maleki Vareki. Microbial engraftment and immune regulation during fecal microbiota transplantation and immune checkpoint inhibitor therapy. Nature Communications 2026; 17(1) doi: 10.1038/s41467-026-76051-z
|
| 3 |
Magdy El-Salhy, Renate Winkel, Christina Casen, Trygve Hausken, Odd Helge Gilja, Jan Gunnar Hatlebakk. Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation. Gastroenterology 2022; 163(4) doi: 10.1053/j.gastro.2022.06.020
|
| 4 |
Manuele Biazzo, Gabriele Deidda. Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases. Journal of Clinical Medicine 2022; 11(14) doi: 10.3390/jcm11144119
|
| 5 |
Xuan Ju, Zhenliang Jiang, Jiayin Ma, Dong Yang. Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis. Nutrients 2024; 16(11) doi: 10.3390/nu16111727
|
| 6 |
Anastasia Andreevna Volodikhina, Aminat Rabadanovna Akhmedova, Marat Borisovich Uzdenov, Milana Lemayevna Dzhabrailova, Rassita Khizirovna Voytleva, Vladislav Ikromzhonovich Achilov. Exploring Approaches to Addressing Gastrointestinal Disorders in Patients with Anxiety. International Journal of Social and Psychological Aspects of Healthcare 2021; 1(1) doi: 10.51847/XhAA49RUml
|
| 7 |
Amal Mohamed Elhusein, Hammad Ali Fadlalmola. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients. Gastroenterology Nursing 2022; 45(1) doi: 10.1097/SGA.0000000000000652
|
| 8 |
Alfonso Benítez-Páez, Annick V. Hartstra, Max Nieuwdorp, Yolanda Sanz.
Species- and strain-level assessment using
rrn
long-amplicons suggests donor’s influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2078621
|
| 9 |
Lu Hang, Yan Zhou, Yang-Yang Meng, Ya Feng, Yin-Shu Wang, Jian-Ye Yuan. Progress in understanding of relationship between short chain fatty acids and irritable bowel syndrome. World Chinese Journal of Digestology 2021; 29(19) doi: 10.11569/wcjd.v29.i19.1102
|
| 10 |
Lina He, Rongping Chen, Bangzhou Zhang, Shuo Zhang, Barkat Ali Khan, Dan Zhu, Zezhen Wu, Chuanxing Xiao, Baolong Chen, Fengwu Chen, Kaijian Hou. Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.930872
|
| 11 |
Mancai Wang, Xiaofeng Xie, Songbo Zhao, Xiaojuan Ma, Zheyuan Wang, Youcheng Zhang. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1136343
|
| 12 |
Theodore Rokkas, Georgina L. Hold. A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2023; 35(4) doi: 10.1097/MEG.0000000000002519
|
| 13 |
Mengying Wang, Yinxi Tan, Huangda Guo, Hexiang Peng, Siyue Wang, Yi Zheng, Tianjiao Hou, Chenghua Gao, Wenyan Xian, Jie Huang, Tao Wu. Sex hormone-binding globulin and sex-specific association between irritable bowel syndrome and type 2 diabetes: a prospective cohort study. Nutrition Journal 2025; 24(1) doi: 10.1186/s12937-025-01155-z
|
| 14 |
Jennifer Couturier, Emily Kenner, Maria Nicula, Fariha Chowdhury, Michael Surette, Nikhil Pai. Protocol for a pilot feasibility randomised controlled trial of fecal microbiota transplantation for adolescent anorexia nervosa. BMJ Open 2026; 16(4) doi: 10.1136/bmjopen-2025-109115
|
| 15 |
Meiyu Yuan, Zhongwei Zhang, Tongying Liu, Hua Feng, Yuhuan Liu, Kai Chen. The Role of Nondigestible Oligosaccharides in Alleviating Human Chronic Diseases by Regulating the Gut Microbiota: A Review. Foods 2024; 13(13) doi: 10.3390/foods13132157
|
| 16 |
IRRITABLE BOWEL SYNDROME: THE ROLE OF GUT MICROBIOTA IN ETIOLOGY AND TREATMENT. A LITERATURE REVIEW. International Journal of Innovative Technologies in Social Science 2026; (1(49)) doi: 10.31435/ijitss.1(49).2026.4612
|
| 17 |
Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Hoon Choi, Isom Jin, Eun Hye Kim, Sungchan Ha, Kisung Kang, Wonseok Lee, HyeLim Choi, Yeon-Ran Kim, Yeong-Jae Seok, Ho-Kyoung Lee, Cheol Min Shin, Dong Ho Lee. Sex-Dependent Microbial and Host Profiles Following Fecal Microbiota and Bifidobacterium longum Treatment in Stress-Induced Gut Dysbiosis. Gut and Liver 2026; 20(5) doi: 10.5009/gnl250440
|
| 18 |
Jiafei Liu, Liqiang Gu, Mingqing Zhang, Shiwu Zhang, Min Wang, Yu Long, Xipeng Zhang. The Fecal Microbiota Transplantation: A Remarkable Clinical Therapy for Slow Transit Constipation in Future. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.732474
|
| 19 |
Anastasia Andreevna Volodikhina, Aminat Rabadanovna Akhmedova, Marat Borisovich Uzdenov, Milana Lemayevna Dzhabrailova, Rassita Khizirovna Voytleva, Vladislav Ikromzhonovich Achilov. Possibilities of Correction of Functional Disorders of the Gastrointestinal Tract in Patients with Anxiety Disorders. Pharmacophore 2022; 13(3) doi: 10.51847/lRJ9ReA6Ft
|
| 20 |
Muhammad Shams, Junaid Ahmed, Aqsa Umar, Abdur Rehman, Komal Sohail, Bushra Javed, Raza Mustafa, FNU Payal, Abdullah Shehryar, Mustafa Khan. Dietary Interventions in Irritable Bowel Syndrome: A Systematic Review of Clinical Outcomes, Microbiota Changes, and Inflammatory Markers. Cureus 2024; doi: 10.7759/cureus.70568
|
| 21 |
Gabriela Piovezani Ramos, Michael Camilleri. Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea. Digestive Diseases and Sciences 2023; 68(5) doi: 10.1007/s10620-022-07700-8
|
| 22 |
Xiaoqiang Zhu, Lijun Zhao, Liang Lei, Yanhong Zhu, Jun Xu, Li Liu. Fecal microbiota transplantation ameliorates abdominal obesity through inhibiting microbiota-mediated intestinal barrier damage and inflammation in mice. Microbiological Research 2024; 282 doi: 10.1016/j.micres.2024.127654
|
| 23 |
Xuemei Li, Qiang Yuan, Hui Huang, Li Wang. Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1695321
|
| 24 |
Maria J. Arzamendi, Yasaman B. Habibyan, Manon Defaye, Adam Shute, Cristiane H. Baggio, Ronald Chan, Christina Ohland, Dominique G. Bihan, Ian A. Lewis, Keith A. Sharkey, Kathy D. McCoy, Christophe Altier, Markus B. Geuking, Yasmin Nasser. Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2409207
|
| 25 |
Motonobu Hamazaki, Tsunaki Sawada, Takeshi Yamamura, Keiko Maeda, Yasuyuki Mizutani, Eri Ishikawa, Satoshi Furune, Kenta Yamamoto, Takuya Ishikawa, Naomi Kakushima, Kazuhiro Furukawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima, Masatoshi Ishigami, Masanao Nakamura, Mitsuhiro Fujishiro. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02408-5
|
| 26 |
Rafael Vieira de Menezes, João Felipe de Paula Pessoa Lapenda, André Galvão Knopp, Maria Fernanda Diniz Ferreira , Felipe Lima Barros Ourem Campos, Maria Luiza Oliveira Costa, Guilherme Salcedo Crusco , Ana Luiza Melo Moura Ferreira, Hugo Rafael De Souza e Silva. TRANSPLANTE DE MICROBIOTA FECAL NO TRATAMENTO DA SÍNDROME DO INTESTINO IRRITÁVEL: UMA REVISÃO DE ESCOPO. Brazilian Medical Students 2025; 10(14) doi: 10.53843/bms.v10i14.742
|
| 27 |
Mina Susanne Weedon-Fekjær, Hege Kampen Pihlstrøm, Harald Weedon-Fekjær, Birgitte Berentsen, Jan Gunnar Hatlebakk, Birgitte Bjerkely, Olga Karin Solberg, Ketil Riddervold Heimdal, Kristin Ørstavik, Trond G. Jenssen, Solrun Sigurdardottir. Gastrointestinal symptoms in adults with Fabry disease and their associations with physical and mental health. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04439-0
|
| 28 |
Maria Napolitano, Ernesto Fasulo, Federica Ungaro, Luca Massimino, Emanuele Sinagra, Silvio Danese, Francesco Vito Mandarino. Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications. Microorganisms 2023; 11(10) doi: 10.3390/microorganisms11102369
|
| 29 |
Magdy El-Salhy, Maura Corsetti, Odd Helge Gilja, Sutep Gonlachanvit, Jan Gunnar Hatlebakk, Dag Arne Lihaug Hoff, Perttu Lahtinen, Johan Axel Lunding, Tarek Mazzawi, Tanya M Monaghan, Bodil Ohlsson, Tanisa Patcharatrakul, Yong Sung Kim, Cheol Min Shin. Towards a Standard Protocol for Fecal Microbiota Transplantation in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 2026; 32(2) doi: 10.5056/jnm26011
|
| 30 |
Magdy El‐Salhy, Tarek Mazzawi, Trygve Hausken, Jan Gunnar Hatlebakk. Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation. Neurogastroenterology & Motility 2022; 34(9) doi: 10.1111/nmo.14353
|
| 31 |
Shuna Hou, Jiachen Yu, Yongshuang Li, Duoyi Zhao, Zhiyu Zhang. Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases. Advanced Science 2025; 12(13) doi: 10.1002/advs.202413197
|
| 32 |
Magdy El-Salhy, Tanisa Patcharatrakul, Sutep Gonlachanvit. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21<sup>st</sup> century. World Journal of Gastroenterology 2021; 27(22): 2921-2943 doi: 10.3748/wjg.v27.i22.2921
|
| 33 |
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Factors underlying the long-term efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome. Microbes and Infection 2024; 26(8) doi: 10.1016/j.micinf.2024.105372
|
| 34 |
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females. Scandinavian Journal of Gastroenterology 2024; 59(4) doi: 10.1080/00365521.2023.2292479
|
| 35 |
Claudia Di Rosa, Annamaria Altomare, Vittoria Terrigno, Florencia Carbone, Jan Tack, Michele Cicala, Michele Guarino. Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients 2023; 15(7) doi: 10.3390/nu15071647
|
| 36 |
Omprakash Shete, Tarini Shankar Ghosh. Normal Gut Microbiomes in Diverse Populations: Clinical Implications.
Annual Review of Medicine
2025; 76(1) doi: 10.1146/annurev-med-051223-031809
|
| 37 |
Liping Liu, Qin Wu, Yuping Chen, Huiling Ren, Qi Zhang, Hengyue Yang, Wenying Zhang, Tingyu Ding, Shujie Wang, Yan Zhang, Yun Liu, Jihu Sun. Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies. International Immunopharmacology 2023; 115 doi: 10.1016/j.intimp.2023.109685
|
| 38 |
Magdy El‐Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Letter: A step forward towards a standard FMT protocol for IBS. Alimentary Pharmacology & Therapeutics 2023; 58(10) doi: 10.1111/apt.17749
|
| 39 |
Praveen Kumar Uppala, Sita K Karanam, Ramaiah Maddi. Science of fecal microbiota transplant: From history to cutting-edge clinical practice. World Journal of Gastrointestinal Endoscopy 2026; 18(1): 113133 doi: 10.4253/wjge.v18.i1.113133
|
| 40 |
Frances Widjaja, Ivonne M. C. M. Rietjens. From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes. Biomedicines 2023; 11(10) doi: 10.3390/biomedicines11102658
|